Screening for hemochromatosis: phenotype versus genotype

Area of Science:

• Medical Genetics
• Gastroenterology
• Public Health

Background:

• Hereditary hemochromatosis is a common inherited disorder in Caucasians, characterized by excessive iron absorption.
• Iron overload from hereditary hemochromatosis can lead to significant clinical manifestations and morbidity.
• Early intervention is crucial for preventing disease-related complications.

Purpose of the Study:

• To highlight the importance of screening for hereditary hemochromatosis in young populations.
• To discuss the advantages and disadvantages of phenotypic and genotypic screening methods.
• To advocate for national screening initiatives to prevent disease morbidity.

Main Methods:

• Review of existing phenotypic screening protocols based on transferrin saturation.
• Consideration of newly available genotypic screening methods.
• Analysis of the impact of early iron-depletion therapy on patient outcomes.

Main Results:

• Most homozygotes for hereditary hemochromatosis eventually develop symptoms if untreated.
• Prophylactic phlebotomy therapy can effectively prevent clinical manifestations.
• Early iron-depletion therapy in homozygotes leads to normal longevity.

Conclusions:

• National screening initiatives for hereditary hemochromatosis are essential for identifying and treating at-risk individuals early.
• Both phenotypic and genotypic screening approaches have unique benefits and drawbacks.
• Early treatment of hereditary hemochromatosis ensures normal health, potentially improving insurance eligibility and blood donation opportunities.